Skip to main navigation Skip to search Skip to main content

Butyrate Makes Macrophages “Go Nuclear” against Bacterial Pathogens

Research output: Contribution to journalShort surveypeer-review

15 Scopus citations

Abstract

Butyrate is a microbial metabolite with pleiotropic effects. Schulthess et al. (2019) report that butyrate preconditioning of macrophages enhances their anti-bacterial preparedness by inducing anti-microbial proteins that restrict bacterial growth. This study augments understanding of how microbial metabolites shape host defense.

Original languageEnglish
Pages (from-to)275-278
Number of pages4
JournalImmunity
Volume50
Issue number2
DOIs
StatePublished - 19 Feb 2019
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2019 Elsevier Inc.

Funding

W.S.G. is a member of the SABs of Kintai Therapeutics, Evelo Biosciences, and Leap Therapeutics. She has consulted for Pfizer Consumer Health, Merck, Celgene, and BiomX in the past two years.

Funders
BiomX
Evelo Biosciences
Kintai Therapeutics
Pfizer Consumer Health
Merck
Celgene

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Butyrate Makes Macrophages “Go Nuclear” against Bacterial Pathogens'. Together they form a unique fingerprint.

    Cite this